Full Text View
Tabular View
No Study Results Posted
Related Studies
Transdermal Lisuride: a Trial for the Treatment of Patients With Restless Legs Syndrome (RLS)
This study is ongoing, but not recruiting participants.
Study NCT00367822   Information provided by Axxonis Pharma AG
First Received: August 22, 2006   Last Updated: April 18, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Restless Legs Syndrome
Additional conditions recognized in this trial
Psychomotor Agitation
Syndrome
More general conditions related to this trial
Disease
Dyskinesias
Dyssomnias
Mental Disorders
Nervous System Diseases
Neurobehavioral Manifestations
Neurologic Manifestations
Parasomnias
Pathologic Processes
Psychomotor Disorders
Signs and Symptoms
Sleep Disorders
Sleep Disorders, Intrinsic
Interventions listed in this trial
Lisuride
Ropinirole
Placebo
More general drug interventions related to this trial
Anti-Dyskinesia Agents
Antiparkinson Agents
Central Nervous System Agents
Dopamine Agents
Dopamine Agonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Serotonin Agents
Serotonin Agonists
Therapeutic Uses
Sponsors listed in this trial
Axxonis Pharma AG


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services